CD274 and neoplasm: MHI-TMX@ALB nanoparticle photosensitizers can reverse tumor hypoxia and inhibit PD-L1 protein expression in the tumor microenvironment, resulting in enhanced efficacy of photodynamic immunotherapy by increasing T cell infiltration (275).